Kidney cancer, version 3.2015 Journal Article
| Authors: | Motzer, R. J.; Jonasch, E.; Agarwal, N.; Beard, C.; Bhayani, S.; Bolger, G. B.; Chang, S. S.; Choueiri, T. K.; Costello, B. A.; Derweesh, I. H.; Gupta, S.; Hancock, S. L.; Kim, J. J.; Kuzel, T. M.; Lam, E. T.; Lau, C.; Levine, E. G.; Lin, D. W.; Michaelson, M. D.; Olencki, T.; Pili, R.; Plimack, E. R.; Rampersaud, E. N.; Redman, B. G.; Ryan, C. J.; Sheinfeld, J.; Shuch, B.; Sircar, K.; Somer, B.; Wilder, R. B.; Dwyer, M.; Kumar, R. |
| Article Title: | Kidney cancer, version 3.2015 |
| Abstract: | The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal carcinoma. These NCCN Guidelines Insights highlight the recent updates/changes in these guidelines, and updates include axitinib as first-line treatment option for patients with clear cell renal carcinoma, new data to support pazopanib as subsequent therapy for patients with clear cell carcinoma after first-line treatment with another tyrosine kinase inhibitor, and guidelines for follow-up of patients with renal cell carcinoma. © 2015 by the National Comprehensive Cancer Network. All rights reserved. |
| Keywords: | cancer chemotherapy; review; cancer recurrence; cancer patient; cancer staging; nuclear magnetic resonance imaging; follow up; computer assisted tomography; practice guideline; kidney carcinoma; nephrectomy; patient care; pazopanib; clinical decision making; continuing education; kidney cancer; axitinib; ablation therapy; disease surveillance; human |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 13 |
| Issue: | 2 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2015-02-01 |
| Start Page: | 151 |
| End Page: | 159 |
| Language: | English |
| PROVIDER: | scopus |
| PUBMED: | 25691606 |
| DOI/URL: | |
| Notes: | Export Date: 2 April 2015 -- Source: Scopus |
Citation Impact
Related MSK Work